Fractyl Health to Participate in the Upcoming December Conferences
Fractyl Health (Nasdaq: GUTS), a metabolic therapeutics company specializing in obesity and Type 2 Diabetes treatments, has announced its participation in two upcoming investor conferences. The company's Co-Founder and CEO, Harith Rajagopalan, M.D., Ph.D., will present at:
- The 7th Annual Evercore ISI HealthCONx Conference (Fireside Chat) on December 3, 2024, at 7:30 AM ET
- The Piper Sandler 36th Annual Healthcare Conference (Fireside Chat) on December 4, 2024, at 1:30 PM ET
Webcast replays will be available on the company's investor relations website.
Fractyl Health (Nasdaq: GUTS), una compagnia di terapie metaboliche specializzata nel trattamento dell'obesità e del Diabete di Tipo 2, ha annunciato la sua partecipazione a due prossimi conferenze per investitori. Il Co-Fondatore e CEO dell'azienda, Harith Rajagopalan, M.D., Ph.D., presenterà:
- La 7ª Edizione della Conferenza Evercore ISI HealthCONx (Fireside Chat) il 3 dicembre 2024, alle 7:30 AM ET
- La 36ª Conferenza Sanitaria Annuale Piper Sandler (Fireside Chat) il 4 dicembre 2024, alle 1:30 PM ET
Le registrazioni del webcast saranno disponibili sul sito web delle relazioni con gli investitori dell'azienda.
Fractyl Health (Nasdaq: GUTS), una empresa de terapias metabólicas especializada en tratamientos para la obesidad y la diabetes tipo 2, ha anunciado su participación en dos próximas conferencias para inversores. El cofundador y CEO de la empresa, Harith Rajagopalan, M.D., Ph.D., presentará en:
- La 7ª Conferencia Anual Evercore ISI HealthCONx (Charla junto a la chimenea) el 3 de diciembre de 2024, a las 7:30 AM ET
- La 36ª Conferencia Anual de Salud de Piper Sandler (Charla junto a la chimenea) el 4 de diciembre de 2024, a la 1:30 PM ET
Las repeticiones del webcast estarán disponibles en el sitio web de relaciones con inversores de la empresa.
Fractyl Health (Nasdaq: GUTS), 비만 및 제2형 당뇨병 치료를 전문으로 하는 대사 요법 회사는 두 개의 다가오는 투자자 회의에 참여할 것이라고 발표했습니다. 회사의 공동 창립자이자 CEO인 Harith Rajagopalan, M.D., Ph.D.가 다음과 같은 발표를 진행할 예정입니다:
- 제7회 Evercore ISI HealthCONx 컨퍼런스 (벽난로 옆 대화) 2024년 12월 3일 오전 7:30 ET
- Piper Sandler 제36회 연례 헬스케어 컨퍼런스 (벽난로 옆 대화) 2024년 12월 4일 오후 1:30 ET
웹캐스트 재방송은 회사의 투자자 관계 웹사이트에서 확인할 수 있습니다.
Fractyl Health (Nasdaq: GUTS), une entreprise de thérapies métaboliques spécialisée dans les traitements contre l’obésité et le diabète de type 2, a annoncé sa participation à deux conférences pour investisseurs à venir. Le co-fondateur et PDG de l'entreprise, Harith Rajagopalan, M.D., Ph.D., présentera lors de :
- La 7e Conférence Annuelle Evercore ISI HealthCONx (Entretien au coin du feu) le 3 décembre 2024, à 7h30 ET
- La 36e Conférence Annuelle sur les Soins de Santé de Piper Sandler (Entretien au coin du feu) le 4 décembre 2024, à 13h30 ET
Les rediffusions du webinaire seront disponibles sur le site web des relations investisseurs de l'entreprise.
Fractyl Health (Nasdaq: GUTS), ein Unternehmen für metabolische Therapien, das sich auf Behandlungen für Fettleibigkeit und Typ-2-Diabetes spezialisiert hat, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen bekannt gegeben. Der Mitbegründer und CEO des Unternehmens, Harith Rajagopalan, M.D., Ph.D., wird auf folgenden Veranstaltungen präsentieren:
- Der 7. Jahrestagung der Evercore ISI HealthCONx (Fireside Chat) am 3. Dezember 2024 um 7:30 Uhr ET
- Der 36. Jahrestagung für Gesundheitswesen von Piper Sandler (Fireside Chat) am 4. Dezember 2024 um 13:30 Uhr ET
Webcast-Wiederholungen werden auf der Investorenrelations-Website des Unternehmens verfügbar sein.
- None.
- None.
BURLINGTON, Mass., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on pioneering new approaches that treat root causes of obesity and Type 2 Diabetes (T2D), today announced that Harith Rajagopalan, M.D., Ph.D., Co-Founder and Chief Executive Officer of the Company, will present at two upcoming investor conferences.
Details of the presentations can be found below.
7th Annual Evercore ISI HealthCONx Conference
Format: Fireside Chat
Date: 12/03/2024
Time: 7:30 AM ET
Piper Sandler 36th Annual Healthcare Conference
Format: Fireside Chat
Date: 12/04/2024
Time: 1:30 PM ET
Webcast replays will be accessible following the live sessions on the Events page of the Investors section on the Company’s website at https://ir.fractyl.com/.
About Fractyl Health
Fractyl Health is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including obesity and T2D. Despite advances in treatment over the last 50 years, obesity and T2D continue to be rapidly growing drivers of morbidity and mortality in the 21st century. Fractyl Health’s goal is to transform metabolic disease treatment from chronic symptomatic management to durable disease-modifying therapies that target the organ-level root causes of disease. Fractyl Health is based in Burlington, MA. For more information, visit www.fractyl.com.
Contacts
Corporate Contact
Lisa Davidson, Chief Financial Officer
ir@fractyl.com, 781.902.8800
Media Contact
Jessica Cotrone, Corporate Communications
jcotrone@fractyl.com, 978.760.5622
Investor Contact
Stephen Jasper Gilmartin Group
stephen@gilmartinir.com, 619.949.3681
FAQ
When is Fractyl Health (GUTS) presenting at the Evercore ISI HealthCONx Conference 2024?
What conferences is Fractyl Health (GUTS) attending in December 2024?
Where can I watch the replay of Fractyl Health's (GUTS) December 2024 conference presentations?
